Dr. Momir  Mikov

Dr. Momir Mikov

Professor
University of Montenegro, Serbia


Highest Degree
Ph.D. in Medical Science from University of Novi Sad, Serbia

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Drug Delivery
62%
Metabolic Studies
90%
Drug Pharmacokinetics
75%
Antidiabetic Drugs
55%

Education

1986

Ph.D.

University of Novi Sad, Serbia

Medical Science

Selected Publications

  1. Stojancevic, M., G. Bojic, H.A. Salami and M. Mikov, 2013. The influence of intestinal tract and probiotics on the fate of orally administered drugs. Curr. Issues Mol. Biol., 16: 55-68.
    PubMed  |  

  2. Stepanov, V., K. Stankov and M. Mikov, 2013. The bile acid membrane receptor TGR5: A novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J. Recept Signal Trans. Res., 33: 213-223.
    CrossRef  |  

  3. Stankov, K., S. Popovic and M. Mikov, 2013. C-KIT signaling in cancer treatment. Curr. Pharm. Des. .
    Direct Link  |  

  4. Stankov, K., A. Sabo and M. Mikov, 2013. Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactions 2013. Drug Dev. Res., 74: 1-14.
    CrossRef  |  

  5. Lalic-Popovic, M., V. Vasovic, B. Milijasevic, S. Golocorbin-Kon, H. Al-Salami and M. Mikov, 2013. Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat. J. Diabetes Res., Vol. 2013. 10.1155/2013/598603.
    CrossRef  |  

  6. Velickovic-Radovanovic, R., M. Mikov, A. Catic-Djordjevic, N. Stefanovic, M. Stojanovic, M. Jokanovic and T. Cvetkovic, 2012. Tacrolimus as a part of immunosuppressive treatment in kidney transplantation patients: Sex differences. Gend Med., 9: 471-480.
    CrossRef  |  

  7. Stojancevic, M., K. Stankov and M. Mikov, 2012. The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease. Can. J. Gastroenterol., 26: 631-637.
    PubMed  |  

  8. Stankov, K., D. Draskovic and M. Mikov, 2012. Ethical and legal aspects of oncogenomics. J. BUON, 17: 383-388.
    PubMed  |  

  9. Stanimirov, B., K. Stankov and M. Mikov, 2012. Pleiotropic functions of bile acids mediated by the farnesoid X receptor. Acta Gastro-Enterol. Belg, 75: 389-398.
    PubMed  |  

  10. Pavlovic, N., K. Stankov and M. Mikov, 2012. Probiotics-interactions with bile acids and impact on cholesterol metabolism. Applied Biochem. Biotechnol., 168: 1880-1895.
    CrossRef  |  

  11. Pavlovic, N., B. Stanimirov, M. Stojancevic, M. Paut-Kusturica, A. Stoimenova, S. Golocorbin-Kon and M. Mikov, 2012. An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and Sweden. Biotechnol. Biotechnol. Equipment, 26: 3236-3241.
    CrossRef  |  

  12. Mikov, I., K. Stankov, V. Vasovic, A. Mikov, S. Golocorbin-Kon and M. Mikov, 2012. Effect of simultaneous exposure to benzene and ethanol on urinary thioether excretion. Int. J. Occup Saf Ergon., 18: 107-111.
    PubMed  |  

  13. Velickovic-Radovanovic, R., M. Mikov, G. Paunovic, V. Djordjevic, M. Stojanovic, T. Cvetkovic and A.C. Djordjevic, 2011. Gender differences in pharmacokinetics of tacrolimus and their clinical significance in kidney transplant recipients. Gend Med., 8: 23-31.
    CrossRef  |  

  14. Sabo, A., Z. Tomic, N. Stilinovic, B. Milijasevic, M. Mikov, S. Vukmirovic and O. Horvat, 2011. Consumption of serum lipid-reducing drugs in Serbia compared with Scandinavian countries: A population-based study, 2004-2008. Pharmacoepidemiol. Drug Safety, 20: 45-49.
    CrossRef  |  

  15. Raskovic, A., N. Stilinovic, J. Kolarovic, V. Vasovic, S. Vukmirovic and M. Mikov, 2011. The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules, 16: 8601-8613.
    CrossRef  |  

  16. Posa, M., V. Guszvany, M. Mikov and J. Canadi, 2011. Effect of sodium salt of ,3alpha, 12alpha-dihydroxy-7-oxo-5beta-cholanoic and 3,7,12-trioxo-5beta-cholanoic acid on verapamile hydrochloride in biophysical-chemical model experiments. J. Serb. Chem. Soc., 76: 189-199.

  17. Perisic, Z., N. Perisic, S. Golocorbin Kon, D. Vesovic, A.M. Jovanovic and M. Mikov, 2011. The influence of probiotics on the cervical malignancy diagnostics quality. Vojnosanit Pregl., 68: 956-960.
    CrossRef  |  

  18. Mikov, I., V. Vasovic, A. Mikov, S. Golocorbin-Kon, K. Stankov and M. Mikov, 2011. Hypoglicemic effect of herbicide 2,4-dichlorophenoxyacetic acid (2,4-D). Pestic. Phytomed. (Belgrade), 25: 349-352.
    CrossRef  |  Direct Link  |  

  19. Lalic, M., A. Pilipovic, S. Golocorbin-Kon, K. Gebauer-Bukurov, K. Bozic, M. Mikov and J. Cvejic, 2011. Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations. Drugs R. D, 11: 53-60.
    Direct Link  |  

  20. Krittaphol, W., A. McDowell, C.D. Thomson, M. Mikov and J.P. Fawcett, 2011. Biotransformation of L-selenomethionine and selenite in rat gut contents. Biol. Trace Elem. Res., 139: 188-196.
    CrossRef  |  

  21. Golocorbin Kon, S. and M. Mikov, 2011. [Counterfeit drugs as a gobal threat to health]. Med. Pregl., 64: 285-290.
    CrossRef  |  

  22. Cekic, V., V. Vasovic, V. Jakovljevic, M. Mikov and A. Sabo, 2011. Hypoglycaemic action of stevioside and а barley and brewer's yeast based preparation in the experimental model on mice. Bosn J. Basic. Med. Sci., 11: 11-16.
    PubMed  |  

  23. Cekic, V., V. Vasovic, V. Jakovljevic, D. Lalosevic, I. Capo, M. Mikov and A. Sabo, 2011. [Effect of chromium enriched fermentation product of barley and brewer's yeast and its combination with rosiglitazone on experimentally induced hyperglycaemia in mice]. Srp. Arh. Celok Lek., 139: 610-618.
    CrossRef  |  

  24. Al-Salami, H., G. Butt, I. Tucker, S. Golocorbin-Kon and M. Mikov, 2011. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet, 37: 99-108.
    CrossRef  |  

  25. Yang, L., H. Zhang, J.P. Fawcett, M. Mikov and I.G. Tucker, 2010. Effect of bile salts on the transport of morphine-6-glucuronide in rat brain endothelial cells. J. Pharm. Sci., 100: 1516-1524.
    CrossRef  |  

  26. Velickovic-Radovanovic, R.M., G. Paunovic, M. Mikov, V. Djordjevic, M. Stojanovic, A. Catic-Djordjevic and T. Cvetkovic, 2010. Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy. Basic Clin. Pharmacol. Toxicol., 106: 505-510.
    CrossRef  |  

  27. Vasovic, V., S. Vukmirovic, M. Pjevic, I. Mikov, M. Mikov and V. Jakovljevic, 2010. Influence of bile acid derivates on tramadol analgesic effect in mice. Eur. J. Drug Metab. Pharmacokinet, 35: 75-78.
    CrossRef  |  

  28. Yang, L., H. Zhang, M. Mikov and I. Tucker, 2009. Physicochemical and biological characterization of monoketocholic acid, a novel permeability enhancer. Mol. Pharm., 6: 448-456.
    CrossRef  |  

  29. Popovic, J., M. Mikov, A. Sabo and V. Jakovljevic, 2009. Evaluation of statistical power function for various diclofenac bioequivalence trials with different subject numbers. Eur. J. Drug Metab. Pharmacokinet, 34: 85-91.
    CrossRef  |  

  30. Lalic, M., J. Cvejic, J. Popovic, K. Bozic, S. Golocorbin-Kon, H. Al-Salami and M. Mikov, 2009. Lamotrigine and valproate pharmacokinetics interactions in epileptic patients. Eur. J. Drug Metab. Pharmacokinet, 34: 93-99.
    PubMed  |  

  31. Kuhajda, I., M. Posa, V. Jakovljevic, V. Ivetic and M. Mikov, 2009. Effect of 12-monoketocholic acid on modulation of analgesic action of morphine and tramadol. Eur. J. Drug Metab. Pharmacokinet, 34: 73-78.
    PubMed  |  

  32. Krittaphol, W., A. McDowell, C.D. Thomson, I.G. Tucker, J.P. Fawcett and M. Mikov, 2009. An improved HPLC method for the investigation of L-selenomethionine metabolism in rat gut contents. Biomed Chromatogr, 23: 1169-1174.
    CrossRef  |  

  33. Kolarovic, J., M. Popovic, M. Mikov, R. Mitic and L. Gvozdenovic, 2009. Protective effects of celery juice in treatments with doxorubicin. Molecules, 14: 1627-1638.
    CrossRef  |  

  34. Golocorbin-Kon, S., M. Mikov, M. Arafat, Z. Lepojevic, I. Mikov, M. Sahman-Zaimovic and Z. Tomic, 2009. Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate microvesicles in rat. Eur. J. Drug Metab. Pharmacokinet, 34: 31-36.
    PubMed  |  

  35. Golocorbin-Kon, S., M. Mikov, M. Arafat, Z. Lepojevic, I. Mikov, M. Sahman-Zaimovic and Z. Tomic, 2009. Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alfa-dihydroxy-12-oxo-5beta-cholanate micro vesicules in rat. Eur. J. Drug Metab. Pharmacokinet, 34: 31-37.

  36. Chen, G., J.P. Fawcett, M. Mikov and I.G. Tucker, 2009. Simultaneous determination of methotrexate and its polyglutamate metabolites in Caco-2 cells by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed Anal., 50: 262-266.
    CrossRef  |  

  37. Chen, G., J.P. Fawcett, M. Mikov and I.G. Tucker, 2009. Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat. J. Pharm. Pharmacol., 61: 953-959.
    CrossRef  |  

  38. Chen, G., J. Fawcett, M. Mikov and I. Tucker, 2009. Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolazers and reduce its intestinal absorption in rat. J. Pharm. Pharmacol., 61: 1-7.

  39. Al-Salami, H., G. Butt, I. Tucker, P.J. Fawcett, S. Golocorbin-Kon, I. Mikov and M. Mikov, 2009. Gliclazide reduces MKC intestinal transport in healthy but not in diabetic rats. Eur. J. Drug Metab. Pharmacokinet, 34: 43-51.
    PubMed  |  

  40. Tomic, Z., B. Milijasevic, A. Sabo, L. Dusan and V. Jakovljevic et al., 2008. Diclofenac and ketoprofen liver toxicity in rat. Eur. J. Drug Metab. Pharmacokinet, 33: 253-260.
    CrossRef  |  

  41. Raskovic, A., M. Mikov, R. Skrbic, V. Jakovljevic, V. Vasovic et al., 2008. Effect of stevioside and sodium salt of monoketocholic acid on glycemia in normoglycemic and diabetic rats. Eur. J. Drug Metab. Pharmacokinet, 33: 17-22.
    PubMed  |  

  42. Posa, M., S. Kevresan, M. Mikov, V. Cirin-Novta and K. Kuhajda, 2008. Critical micellar concentrations of keto derivatives of selected bile acids: Thermodynamic functions of micelle formation. Colloids Surf B Biointerfaces, 64: 151-161.
    CrossRef  |  

  43. Mikov, M., H. Al-Salami, S. Golocorbin-Kon, R. Skrbic, A. Raskovic and P.J. Fawcett, 2008. The influence of 3 alpha,7 alpha-dihydroxy-12-keto-5 beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes. Eur. J. Drug Metab. Pharmacokinet, 33: 137-142.

  44. Kojic-Damjanov, S., M. Djeric, M. Mikov, K. Kuhajda and S. Kevresan, 2008. Influence of sodium monoketocholate on the hypolipidemic activity of lovastatin in healthy and diabetic rats. Eur. J. Drug. Metab. Pharmacokinet., 33: 77-84.
    CrossRef  |  

  45. Al-Salami, H., G. Butt, I. Tucker, R. Skrbic, S. Golocorbin-Kon and M. Mikov, 2008. Probiotic treatment proceeded by a single dose of bile acid and gliclazide exert the most hypoglycemic effect in type 1 diabetic rats. Med. Hypotheses Res., 4: 93-101.

  46. Al-Salami, H., G. Butt, I. Tucker and M. Mikov, 2008. Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics. Methods Find Exp. Clin. Pharmacol., 30: 107-113.
    CrossRef  |  

  47. Al‐Salami, H., G. Butt, I. Tucker, R. Skrbic, S. Golocorbin‐Kon and M. Mikov, 2008. Probiotic pre‐treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch. Drug. Inform., 1: 35-41.
    CrossRef  |  

  48. Posa, M., S. Kevresan, M. Mikov, V. Cirin-Novta, C. Sarbu and K. Kuhajda, 2007. Determination of critical micellar concentrations of cholic acid and its keto derivatives. Colloids Surf. B: Biointerfaces, 59: 179-183.
    CrossRef  |  

  49. Posa, M., S. Kevresan, M. Mikov, V. Cirin-Novta and K. Kuhajda, 2007. Effect of cholic acid and its keto derivatives on the analgesic action of lidocaine and associated biochemical parameters in rats. Eur. J. Drug. Metab. Pharmacokinet., 32: 109-117.
    PubMed  |  Direct Link  |  

  50. Popovic, M., J. Kolarovic, M. Mikov, S. Trivic and B. Kaurinovic, 2007. Anthracycline-based combined chemotherapy in the mouse model. Eur. J. Drug. Metab. Pharmacokinet., 32: 101-108.
    PubMed  |  Direct Link  |  

  51. Mikov, M., N.S. Boni, H. Al-Salami, K. Kuhajda, S. Kevresan, S. Golocorbin-Kon and J.P. Fawcett, 2007. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats. Eur. J. Drug. Metab. Pharmacokinet., 32: 7-12.
    PubMed  |  Direct Link  |  

  52. Lee, H.J., B. Fung, P. Lim, F. Tang, A. Tominari, M. Mikov and P. Fawcett, 2007. Role of gut microflora in drug metabolism-pets or pests. New Zealand Pharamcy, 27: 21-24.

  53. Cvejic, J., S. Tambutte, S. Lotto, M. Mikov and I. Slacanin, 2007. Allemand D determination of cantaxantin in the red coral (Corallium rubrum) from marselle by HPLC combined with UV and MS detection. Mar. Biol., 152: 855-862.

  54. Al-Salami, H., H. Kansara, J. King, B. Morar, B. Jayathilaka, J.P. Fawcett and M. Mikov, 2007. Bile Acids: A bitter sweat remedy for diabetes. New Zealand Pharamcy J., 27: 17-20.

  55. Yee, E., M. Kong, P. Hung, G. Wong, E. Huang, P. Tsai, J.P. Fawcett and M. Mikov, 2006. Sulfasalazine-old drug, new tricks. New Zealand Pharmacy, 26: 23-28.

  56. Vasovic, V., S. Vukmirovic, M. Posa, M. Mikov, A. Raskovic and V. Jakovljevic, 2006. Effect of rat pretreatment with aqueous solutions of stevioside and bile acids on the action of certain cardioactive drugs. Eur. J. Drug. Metab. Pharmacokinet., 31: 311-314.
    CrossRef  |  

  57. Popovic, J., R. Mitic, A. Sabo, M. Mikov, V. Jakovljevic and K. Dakovic-Svajcer, 2006. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: Study in healthy volunteers. Eur. J. Drug. Metab. Pharmacokinet., 31: 87-96.
    CrossRef  |  

  58. Mikov, M., J.P. Fawcett, K. Kuhajda and S. Kevresan, 2006. Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents. Eur. J. Drug. Metab. Pharmacokinet., 31: 237-251.
    CrossRef  |  

  59. Mikov, M., H.J. Lee and J.P. Fawcett, 2006. The influence of probiotic treatment on sulfasalazine metabolism in rat gut contents. Asian J. Pharmacodynamics Pharmacokinetics, 6: 337-342.

  60. Mikov, M. and J.P. Fawcett, 2006. Chemistry, biosynthesis, analysis, chemical and metabolic transformations and pharmacology. Eur. J. Drug. Metab. Pharmacokinet., 31: 133-134.

  61. Kuhajda, K., S. Kevresan, J. Kandrac, J.P. Fawcett and M. Mikov, 2006. Chemical and metabolic transformations of selected bile acids. Eur. J. Drug. Metab. Pharmacokinet., 31: 179-235.
    CrossRef  |  

  62. Kuhajda, K., J. Kandrac, S. Kevresan, M. Mikov and J.P. Fawcett, 2006. Structure and origin of bile acids: An overview. Eur. J. Drug. Metab. Pharmacokinet., 31: 135-143.
    CrossRef  |  

  63. Kevresan, S., K. Kuhajda, J. Kandrac, J.P. Fawcett and M. Mikov, 2006. Biosynthesis of bile acids in mammalian liver. Eur. J. Drug. Metab. Pharmacokinet., 31: 145-156.
    CrossRef  |  

  64. Kandrac, J., S. Kevresan, J.K. Gu, M. Mikov, J.P Fawcett and K. Kuhajda, 2006. Isolation and determination of bile acids. Eur. J. Drug. Metab. Pharmacokinet., 31: 157-177.
    PubMed  |  Direct Link  |  

  65. Mikov, M., A. Raskovic, E. Jakovljevic, D. Dudvarski and J.P. Fawcett, 2005. Influence of the bile salt sodium 3α, 7α-dihydroxy-12-oxo-5β-cholanate on ampicillin pharmacokinetics in rats. Asian J. Drug. Metab. Pharmacokinet., 5: 197-200.

  66. Boulton, K., A. Martin, R. Polloc, M. Tillman and M. Mikov, 2005. Bile acids as absorption promoters. New Zealand Pharm., 25: 31-34.

  67. Bojic-Milicevic, G., M. Mikov and R. Dautovic, 2005. [Common errors in diagnosis and management of urinary tract infections-microbiological aspects]. Med. Pregl., 56: 380-387.
    PubMed  |  Direct Link  |  

  68. Bojic-Milicevic G., M. Mikov, L.j. Suvajdzic and S. Golocorbin-Kon, 2005. Protection of urogenital tract against infections by probiotics. Med. Danas, 4: 99-106.

  69. Vasovic, V., M. Mikov, K. Kuhajda, S. Kevresan, 2004. The ingluence of bile acid derivatives on the hypnotic effect of pentobarbital in the rat. Pharmaca Iugoslavica, 42: 17-19.

  70. Raskovic, A., V. Jakovljevic, M. Mikov and M. Gavrilovic, 2004. Joint effect of commercial preparations of Stevia rebaudiana Bertoni and sodium monoketocholate on glycemia in mice. Eur. J. Drug. Metab. Pharmacokinet, 29: 83-86.
    PubMed  |  Direct Link  |  

  71. Mikov, M.I., M. Mikov and J. Siriski, 2004. Chronic exposure to toluene and xylene vapours and their effects on health of workers in the production of paints and varnishes. Arch. Toxicol. Kinet Xenobiot Metab., 2: 15-24.

  72. Mikov, M., S. Kevresan, K. Kuhajda, V. Jakovljevic and V. Vasovic, 2004. 3alfa,7alfa-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator. Pol. J. Pharmacol., 56: 367-371.

  73. Vasovic, V., M. Mikov, K. Kuhajda and S. Kevresan, 2003. The influence of bile acid derivatives on analgesic effect of morphine in rat. Pharmaca Iugoslavica, 41: 11-14.

  74. Mikov, M., K. Kuhajda and J. Kandrac, 2003. New trends in therapeutic application of bile acids. Medicinski Pregl., 56: 237-242.

  75. Kljajic, V., M. Mikov, L.j. Vlaski, S. Savovic and J. Jovicevic, 2003. Subjective disturbances of the health volunteers after acute intake of higher therapeutical dosages of the carbamazepine. Pharmaca Iugoslavica, 41: 19-22.

  76. Ubavic, M., A. Raskovic, M. Mikov, K. Kuhajda, S. Kevresan, S. Bascarevic and V. Vasovic, 2002. The future of therapeutic use of bile acids. Arch Toxicol. Kinet Xenobiot Metab., 10: 108-114.

  77. Potsides, C.Y. and M. Mikov, 2002. Good clinical Practice with good laboratory practice-development owerview. Pharmaca Iugoslavica, 40: 25-26.

  78. Vasovic, V., M. Mikov, K. Kuhajda, S. Kevresan and V. Jakovljevic, 2001. The influence of sodium salt of monoketocholic acid on quinine transport into the central nervous system in rats. Iugoslav Physiol. Pharmacol. Acta, 37: 89-98.

  79. Ubavic, M., A. Raskovic, M. Mikov, S. Kevresan and K. Kuhajda, 2000. The influence of sodium monoketocholate on ciclosporine induced functional disturbances of rat liver and kidney. Scripta Med., 31: 55-61.

  80. Mikov, I., M. Milosevic, A. Mikov and M. Mikov, 2000. Increased urinary excretion of thioethers as a marker for detecting exposure to herbicide containing 2, 4-dichlorophenoxyacetic acid dimethylamine-experimental study on mice. Ann. Agric. Environ. Med., 7: 61-63.
    Direct Link  |  

  81. Mikov, I., A. Mikov, J. Siriski, M. Mikov and V. Milovanov, 2000. Effect of simultaneous exposure to benzene and ethanol on urinary phenol excretion in mice. J. Occup. Health, 42: 258-259.
    CrossRef  |  

  82. Kuhajda, K., S. Kevresan, M. Mikov and D. Miljkovic, 2000. Influence of 3 alfa, 7 alfa dihydroxy-12oxo-5beta cholanate on blood glucose levels in rats. Toxicol. Kinet Xenobiot Metab., 8: 304-308.

  83. Kolarovic, J., M. Petkovic, M. Mikov, I. Mikov and A. Mikov, 2000. The influence of herbicide 2,4-dichlorphenoxyacetic acid on caffeine metabolism and urinary concentration of thioethers in mice. Arch Toxicol. Kinet Xenob. Metabol., 8: 29-35.

  84. Samojlik, I., A. Raskovic, K. Dakovic-Svajcer, M. Mikov and V. Jakovljevic, 1999. The effect of paracetamol on peritoneal reflex after single and multiple grapefruit ingestion. Exp. Toxicol. Pathol., 51: 418-420.
    CrossRef  |  Direct Link  |  

  85. Kolarovic, J., M. Mikov and V. Ristovski, 1999. The influence of anesthetic concentrations of enflurane and ethanol on caffeine metabolism in mice. Exp. Toxicol. Pathol., 51: 347-351.
    CrossRef  |  Direct Link  |  

  86. Kolarovic, J. and M. Mikov, 1999. The influence of doxorubicin and N-acetylcysteine on caffeine metabolism in mice. Arch. Toxicol. Kinet Xenobiot Metab., 6: 727-736.

  87. Mikov, M., J. Caldwell and R.L. Smith, 1998. The role of intestinal microflora in the formation of the methylthio adduct metabolites of paracetamol. Biochem. Pharmacol., 37: 1445-1449.

  88. Banic, B., M. Stanulovic, K. Dakovic-Svajcer, M. Jakovljevic, V. Mikov, A. Sabo and J. Popovic, 1997. Professional and social responsibilities of clinical pharmacology. Med. Pregl., 50: 451-456.
    PubMed  |  Direct Link  |  

  89. Bojic-Milicevic, G., M. Mikov and B. Milicevic, 1996. Gut microflora and verapamil metabolism. Arch. Toxicol. Kinet Xenobiot Metab., 4: 103-108.

  90. Bojic-Milicevic, G. and M. Mikov, 1996. Gut microglora and its contribution to formation of methylthio metabolites of paracetamol. Scripta Med., 27: 1-3.

  91. Radosavac, A., I. Mikov, M. Popovic, V. Jakovljevic and M. Mikov, 1995. Effeect of N-acetylcysteine on cocaine toxicity. Iugoslav Physiol. Pharmacol. Acta, 31: 367-371.

  92. Popovic, J., M. Mikov and V. Jakovljevic, 1995. Pharmacokinetics of carbamazepine derived from a new tablet formulation. Eur. J. Drug Metab. Pharmacokinet., 20: 297-300.
    CrossRef  |  

  93. Mikov, M., 1995. Paracetamol-3-cysteine acetylation in mice. Iugoslav Phisiol. Pharmacol. Acta, 31: 355-360.

  94. Mikov, I., A. Radosavac, V. Jakovljevic, M. Popovic and M. Mikov, 1995. Benzene-ethanol interaction and hepatotoxicity. Iugoslav Physiol. Pharmacol. Acta, 31: 361-365.

  95. Jakovljevic, V., M. Popovic, V. Lukic, A. Sabo and M. Mikov, 1995. Effect of linum usitatissimum L. on some biochemical parameters of rat liver function. Iugolav Physiol. Pharmacol. Acta, 31: 431-435.

  96. Bojic-Milicevic, G. and M. Mikov, 1995. Gut microflora metabolic activity. Arch. Toxicol. Kinet Xenobiotic Metab., 3: 55-64.

  97. Popovic, M., V. Jakovljevic, M. Stanulovic, M. Mikov and J. Nerudova, 1994. Single and combined efect of phenobarbitone and purine drugs on some biochemical parameters of rat liver. Arch. Toxicol. Kinet Xenobiot Metab., 2: 701-711.

  98. Popovic, J., M. Mikov and V. Jakovljevic, 1994. Pharmacokinetic analysis of a new acenocoumarol tablet formulation during a bioequivalence study. Eur. J. Drug Metab. Pharmacokinet., 19: 85-89.
    CrossRef  |  

  99. Mikov, M., 1994. The metabolism of drugs by the gut flora. Eur. J. Drug Metab. Pharmacokinet., 19: 201-207.
    CrossRef  |  

  100. Mikov, M., 1994. Metabolism and toxicity of paracetamol thiometabolites-the origin and fate of 3-methylthio paracetamol. Arch. Toxicol. Kinet Xenobiot Metab., 2: 421-421.

  101. Popovic, M., V. Lukic, V. Jakovljevic and M. Mikov, 1993. The effect of the radish (Raphanus sativus ssp niger) juice on liver function. Fitoterapia, 64: 229-231.
    Direct Link  |  

  102. Mikov, M. and J. Popovic, 1993. Availability and metabolism of paracetamol administered in the form of tablets or suppositories to healthy volunteers. Arch. Toxicol. Xenob Mtab., 1: 61-68.

  103. Stanulovic, M., B. Banic, K. Dakovic-Svajcer, V. Jakovljevic and A. Sabo et al., 1992. Adverse reactions of drugs: 25 years of WHO and 20 years in Yugoslavia. Pharmaca, 30: 109-115.

  104. Popovic, J., M. Mikov, O. Laban-Boic, D. Simic, L.J. Djukic, B. Banic and M. Stanulovic, 1992. Adverse effect spontaneous reporting and FR Yugoslavia. Pharmaca, 30: 85-92.

  105. Popovic, J., M. Mikov and V. Jakovljevic, 1992. Pharmacokinetics of ticlopidine derived from a new tablet formulation. Acta Biol. Med. Exp., 17: 49-52.

  106. Mikov, M., J. Popovic, B. Banic and M. Stanulovic, 1992. Adverse effects of drugs reported to regional centre Novi sad 1980-1990. Pharmaca, 30: 15-20.

  107. Mikov, M., 1992. The prevention of paracetamol toxicity by caffeine in mice. Acta Biol. Med. Exp., 17: 35-38.

  108. Al-Waiz, M., M. Mikov, S.C. Mitchell and R.L. Smith, 1992. The exogenous origin of trimethylamine in the mouse. 41 Metabolism,: 135-136.
    CrossRef  |  

  109. Mikov, M.I. and M. Mikov, 1991. Morbidity of workers exposed to organic solvents in varnish industry. Zastita Radnika Na Radu, 21: 48-52.

  110. Mikov, M.I., A. Mihajlov, M. Mikov and J. Siriski, 1989. The influence of air pollution with organic solvents on exposed workers health status. Zastita Radnika Na Radu, 12: 54-56.

  111. Mikov, M.I. and M. Mikov, 1989. Influence of changing life styles and working conditions on the health status of agricultural workers. Agric. Med. Rural. Health, 13: 42-47.

  112. Mikov, M., 1988. Acetylsalicylic acid in preeclampsia prevention. Pharmaca, 25: 234-235.

  113. Visnjevac, V. and M. Mikov, 1986. Smoking and carboxyhaemoglobin concentrations in mothers and their newborn infants. Human Toxicol., 5: 175-177.
    CrossRef  |  

  114. Mikov, M.I. and M. Mikov, 1985. Poisonings in agriculture. Srp. Arh. Celok Lek, 113: 909-917.

  115. Mikov, M., 1985. Metabolic consequences of dichlorvos pretreatment in mice. Privreda, 3: 10-12.

  116. Mikov, M.1., 1982. Hearing loss in forest workers-motor saw operators. IAAMRH J., 7: 54-58.